课题基金 / 基金详情

Recombination in enteroviruses: the genetics, cell biology and biochemistry of a biphasic replicative mechanism of virus evolution

Recombination in enteroviruses: the genetics, cell biology and biochemistry of a biphasic replicative mechanism of virus evolution
肠道病毒重组:病毒进化双相复制机制的遗传学、细胞生物学和生物化学
批准号:
BB/M009343/1
负责人:
David Evans
金额:
$51.35万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

David Evans的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many of the most important human and animal virus pathogens have positive strand RNA genomes. These include, for example, poliovirus, foot and mouth disease virus and deformed wing virus of honeybees. The majority of these RNA viruses evolve very rapidly, generating large populations of highly divergent progeny. This variation helps the virus evade the host immune system - including escaping immunity induced by vaccines - and may enable the virus to spread more efficiently to new hosts, including cross-species transfer. The variation in the virus population is due to two things; the virus has an error-prone polymerase enzyme which, through mis-incorporation, results in imprecise copying during virus replication. This mis-incorporation can result in up to 0.1% divergence in newly synthesized virus genomes. Secondly, if two related viruses co-infect the same cell, the virus can recombine. Recombination facilitates very much more extensive changes of the virus genome - up to 60% in many cases. Recombinant viruses are essentially hybrids, with part of the virus genome derived from one parent, and part from the other parent. Clearly, by combining such extensive regions of two different viruses there are opportunities for very significant changes in the phenotype i.e. the host range, tissues tropism or pathogenic potential, of the resulting virus.Our laboratory has demonstrated the evolution of a virulent recombinant form of deformed wing virus of honeybees which appears to be associated with global disease. Other studies have shown the evolution of neurovirulent poliovirus in a poorly vaccinated population following recombination with a related co-circulating virus. The error-prone polymerases of positive strand RNA viruses are well characterised. In contrast, the process of recombination is only poorly understood. We have developed an assay that, for the first time, allows the recombination process to be divided into two parts - an initial strand transfer event and a secondary resolution event that markedly increases the fitness of the recombinant virus. We propose to use this assay to provide the first detailed analysis of the mechanism of recombination.Our assay unequivocally demonstrates that the generation of a recombinant virus goes via an intermediate in which there are duplications of parts of the virus genome. "Evolution by duplication" is one of the fundamental processes in virus evolution, in which individual genes are duplicated and then can subsequently independently evolve through acquisition of point mutations. The assay we have developed allows this process to be studied experimentally. We will use enteroviruses as a model system; these viruses are generally well-characterised, there are good laboratory systems for their analysis and they are representative of the types of viruses of humans and animals in which recombination is both observed and problematic. We have over 25 years experience studying this group of viruses, in humans and animals.We will study how the sequence of the virus contributes to the frequency and site of recombination. We will analyse where this process occurs in cells and the contribution made to this event by defined cellular proteins. Finally we will investigate the biochemical mechanism involved in the primary recombination (strand transfer) and resolution events. These studies will contribute to an understanding of the fundamental mechanism of the recombination process which is a major driving force in virus evolution. Additionally, by defining the viral and cellular proteins that are involved it will enable the future control, exploitation or inhibition, of recombination - for example, in vaccines of the future.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/nar/gkw567
发表时间: 2016-08-19
期刊: Nucleic acids research
影响因子: 14.9
作者: [Woodman A, Arnold JJ, Cameron CE, Evans DJ]
通讯作者: Evans DJ
DOI: 10.1371/journal.ppat.1009676
发表时间: 2021-08
期刊: PLoS pathogens
影响因子: 6.7
作者: [Bentley K, Alnaji FG, Woodford L, Jones S, Woodman A, Evans DJ]
通讯作者: Evans DJ
DOI: 10.3390/v13122390
发表时间: 2021-11-29
期刊: Viruses
影响因子: --
作者: [Bentley K, Tee HK, Pearson A, Lowry K, Waugh S, Jones S, Chan YF, Evans DJ]
通讯作者: Evans DJ
DOI: 10.3390/v14050916
发表时间: 2022-04-28
期刊: Viruses
影响因子: --
作者: []
通讯作者:
Birmingham Nuclear Physics Consolidated Grant 2023
  • 批准号:
    ST/Y00034X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $211.48万
  • 财政年份:
    2024
  • 负责人:
    David Evans
  • 依托单位:
Mechanistically understanding biomineralisation and ancient ocean chemistry changes to facilitate robust climate model validation
  • 批准号:
    EP/Y034252/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $222.77万
  • 财政年份:
    2023
  • 负责人:
    David Evans
  • 依托单位:
Birmingham Nuclear Physics Consolidated Grant 2020
  • 批准号:
    ST/V001043/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $220.8万
  • 财政年份:
    2021
  • 负责人:
    David Evans
  • 依托单位:
Collaborative Research: Paleomagnetism and Geochronology of Mafic Dikes in Morocco, Reconstructing West Africa in Proterozoic Supercontinents
  • 批准号:
    1953549
  • 项目类别:
    Standard Grant
  • 资助金额:
    $39.04万
  • 财政年份:
    2020
  • 负责人:
    David Evans
  • 依托单位:
海外基金